(Q40561027)

21 September 2017

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells (English)

1 reference

21 September 2017

1 reference

Wasim Chowdhury

7

0 references

Martine Lamfers

object named as

Martine Lamfers

5

0 references

author name string

Markus D Sachs

1

1 reference

21 September 2017

Meera Ramamurthy

2

1 reference

21 September 2017

Henk van der Poel

3

1 reference

21 September 2017

Thomas J Wickham

4

1 reference

21 September 2017

Winald Gerritsen

6

1 reference

21 September 2017

Ying Li

8

1 reference

21 September 2017

Mark P Schoenberg

9

1 reference

21 September 2017

Ronald Rodriguez

10

1 reference

21 September 2017

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

477-486

1 reference

21 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700726

21 September 2017

0 references

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Management of superficial bladder cancer with intravesical chemotherapy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Alkaline phosphatase activity in human bladder tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Adenovirus-mediated suicide gene therapy for experimental bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Prostate cancer prevention strategies using antiproliferative or differentiating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Variability of cell surface glycoconjugates--relation to differences in cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700726

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference